Literature DB >> 26927727

Impact of HLA-Mismatch in Unrelated Donor Hematopoietic Stem Cell Transplantation: A Meta-Analysis.

Natasha Kekre1, Kimberley S Mak2, Konrad H Stopsack3, Moritz Binder3, Kazusa Ishii4, Elsa Brånvall5, Corey S Cutler6.   

Abstract

The magnitude of risk associated with 9/10 mismatched unrelated donor (MMURD) hematopoietic stem cell transplantation and that of mismatches at the individual HLA loci remain unclear. We performed a meta-analysis to assess the difference in clinical outcomes between matched unrelated donor (MUD) and MMURD transplantation. A comprehensive search of Medline and Embase for manuscripts regarding transplantation outcomes in primarily adult patients with hematologic malignancies was performed. The pooled effect estimates were calculated using DerSimonian-Laird random effects models. A total of 13 studies were included, reporting on 13,446 transplants. 9/10 MMURD transplantation was associated with worse overall survival compared to 10/10 MUD transplantation (pooled HR: 1.27, 95% CI: 1.12-1.45; n = 7 studies). Mismatch at HLA-A, -B, or -C was associated with significantly worse overall survival compared to MUD transplantation, while there was no significant difference associated with -DQ or -DPB1 mismatch. Inferior survival associated with HLA-DRB1 mismatch could not be ruled out. Data on acute and chronic graft-versus-host disease were scarce but favored MUD transplantation. In summary, this meta-analysis of the available literature favored MUD over MMURD transplantation in hematologic malignancies and further quantifies the risks associated with specific HLA-allele mismatches. Am. J. Hematol. 91:551-555, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26927727     DOI: 10.1002/ajh.24342

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1.

Authors:  Jurjen Versluis; Myriam Labopin; Annalisa Ruggeri; Gerard Socie; Depei Wu; Liisa Volin; Didier Blaise; Noel Milpied; Charles Craddock; Ibrahim Yakoub-Agha; Johan Maertens; Per Ljungman; Anne Huynh; Mauricette Michallet; Eric Deconinck; Patrice Chevallier; Jakob Passweg; Fabio Ciceri; Mohamad Mohty; Jan J Cornelissen; Arnon Nagler
Journal:  Blood Adv       Date:  2017-02-28

2.  Selection of matched unrelated donors moving forward: from HLA allele counting to functional matching.

Authors:  Katharina Fleischhauer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 3.  Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis.

Authors:  Ruxiu Tie; Tiansong Zhang; Bo Yang; Huarui Fu; Biqing Han; Jian Yu; Yamin Tan; He Huang
Journal:  Oncotarget       Date:  2017-04-18

Review 4.  Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism.

Authors:  Alice Bertaina; Marco Andreani
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

5.  [Autologous versus unrelated donor stem cell transplantation for adults with primary acute myeloid leukemia in first remission].

Authors:  J F Yao; G X Zhang; D L Yang; Y He; J L Wei; W H Zhai; E L Jiang; R L Zhang; S Z Feng; M Z Han
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-05-14

Review 6.  Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.

Authors:  Ali Salman; Vishal Koparde; Charles E Hall; Max Jameson-Lee; Catherine Roberts; Myrna Serrano; Badar AbdulRazzaq; Jeremy Meier; Caleb Kennedy; Masoud H Manjili; Stephen R Spellman; Dayanjan Wijesinghe; Shahrukh Hashmi; Greg Buck; Rehan Qayyum; Michael Neale; Jason Reed; Amir A Toor
Journal:  Front Immunol       Date:  2018-10-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.